Fidelis Capital Partners LLC Makes New $220,000 Investment in CME Group Inc. (NASDAQ:CME)

Fidelis Capital Partners LLC purchased a new position in CME Group Inc. (NASDAQ:CME) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 967 shares of the financial services provider’s stock, valued at approximately $220,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CME. Norden Group LLC purchased a new stake in CME Group in the first quarter worth approximately $274,000. Private Advisor Group LLC grew its holdings in shares of CME Group by 3.9% in the first quarter. Private Advisor Group LLC now owns 4,592 shares of the financial services provider’s stock worth $989,000 after acquiring an additional 172 shares during the period. Mission Wealth Management LP grew its holdings in shares of CME Group by 0.8% in the first quarter. Mission Wealth Management LP now owns 10,579 shares of the financial services provider’s stock worth $2,277,000 after acquiring an additional 86 shares during the period. Prosperity Consulting Group LLC purchased a new stake in CME Group during the first quarter valued at $237,000. Finally, Mirae Asset Global Investments Co. Ltd. lifted its holdings in CME Group by 33.4% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 105,960 shares of the financial services provider’s stock valued at $22,812,000 after acquiring an additional 26,536 shares during the period. 87.75% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CME has been the subject of several research reports. Keefe, Bruyette & Woods upped their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. JPMorgan Chase & Co. upped their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Piper Sandler lifted their price target on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday. Morgan Stanley upped their price objective on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. Finally, Bank of America lifted their target price on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $222.73.

Insider Buying and Selling at CME Group

In related news, insider Timothy Francis Mccourt sold 1,374 shares of the business’s stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, insider Timothy Francis Mccourt sold 1,374 shares of the business’s stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now owns 7,275 shares in the company, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,221 shares of company stock valued at $3,351,895 in the last 90 days. Insiders own 0.30% of the company’s stock.

CME Group Stock Performance

NASDAQ:CME opened at $225.36 on Friday. The stock has a 50-day moving average price of $220.36 and a 200 day moving average price of $209.34. The stock has a market capitalization of $81.14 billion, a P/E ratio of 25.64, a P/E/G ratio of 7.76 and a beta of 0.55. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.36. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the firm posted $2.25 EPS. The company’s revenue was up 18.4% on a year-over-year basis. Equities research analysts forecast that CME Group Inc. will post 10.04 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a $1.15 dividend. The ex-dividend date was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.04%. CME Group’s dividend payout ratio is currently 52.33%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.